1. Others Vitamin D Related/Nuclear Receptor Metabolic Enzyme/Protease
  2. Glutathione S-transferase Pregnane X Receptor (PXR) Environmental Pollutants Estrogen Receptor/ERR FXR
  3. Benoxacor

Benoxacor (CGA 154281) is a herbicide safener and xenobiotic metabolism regulator. Benoxacor protects maize from the toxicity of metolachlor mainly by inducing detoxifying enzymes such as Glutathione S-transferase. Benoxacor also activates FXR, PXR and ERRα, and inhibits aromatase (aromatase). However, Benoxacor exhibits potential subacute oral toxicity and a high risk of hepatotoxicity in animal models. Benoxacor induces reactive oxygen species accumulation, interferes with embryonic heart development, and causes increased liver and kidney weights as well as alterations in gut microbiota in mice. Benoxacor can be used in studies related to hepatic steatosis, infertility, breast cancer and developmental toxicity.

For research use only. We do not sell to patients.

Benoxacor

Benoxacor Chemical Structure

CAS No. : 98730-04-2

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Benoxacor:

Top Publications Citing Use of Products

View All Estrogen Receptor/ERR Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Benoxacor (CGA 154281) is a herbicide safener and xenobiotic metabolism regulator. Benoxacor protects maize from the toxicity of metolachlor mainly by inducing detoxifying enzymes such as Glutathione S-transferase. Benoxacor also activates FXR, PXR and ERRα, and inhibits aromatase (aromatase). However, Benoxacor exhibits potential subacute oral toxicity and a high risk of hepatotoxicity in animal models. Benoxacor induces reactive oxygen species accumulation, interferes with embryonic heart development, and causes increased liver and kidney weights as well as alterations in gut microbiota in mice. Benoxacor can be used in studies related to hepatic steatosis, infertility, breast cancer and developmental toxicity[1][2][3].

IC50 & Target

ERRα

 

In Vitro

Benoxacor (5 μM; 0-30 min) is metabolized by liver microsomes from male C57BL/6 mice in a time-dependent and enantioselective manner. Cytochrome P450 enzymes primarily metabolize the E2-benoxacor enantiomer, while microsomal carboxylesterases mainly metabolize the E1-benoxacor enantiomer. The intrinsic clearance of microsomal CYP-mediated elimination is 1.05 mL/min/mg protein, with a normalized clearance of 40.22 mL/min/g liver, whereas the intrinsic clearance of microsomal CES-mediated elimination is 0.54 mL/min/mg protein, with a normalized clearance of 20.77 mL/min/g liver[1].
Benoxacor (5 μM; 0-30 min) is metabolized in a time-dependent and enantioselective manner by glutathione S-transferase in the liver cytosol of male C57BL/6 mice, with an intrinsic clearance rate of 1.46 mL/min/mg protein and a normalized clearance rate of 132.52 mL/min/g liver for GST-mediated elimination[1].
Benoxacor (10 μM; 0.25-48 h) is rapidly taken up by suspension-cultured cells of maize (cultivar: Black Mexican Sweet, same below), and the uptake amount increases continuously within 48 h after treatment with 10 μM[3].
Treatment of maize suspension-cultured cells with Benoxacor (10 μM; 0-48 h) doubles the activity of GST-M, a change detectable as early as 4 h post-treatment and peaking at 24 h[3].
Benoxacor (10 μM; 24 h) increases the activities of three distinct GSTs (a, c, d) isolated via anion exchange chromatography from treated maize suspension-cultured cells[3].
Isolation of GST fractions (b, c, d) from maize suspension-cultured cells treated with Benoxacor (10 μM; 24 h) reveals GST polypeptides (26,000-27,000 Mr) that cross-react with maize GST I and GST I/III antisera, a pattern consistent with that observed in benzofenap-treated maize seedlings[3].
Treatment of maize suspension-cultured cells with Benoxacor (10 μM; 24 h) increases GST-M activity by 3-fold, and this effect is partially blocked by pre-treatment with Cycloheximide (HY-12320) (10/100 μM; 2 h), indicating that this induction activity requires de novo protein synthesis[3].
Treatment of maize suspension-cultured cells with Benoxacor (10 μM; 24 h) increases GST-M activity by 3-fold, and this enhancing effect is significantly blocked by pretreatment with Cordycepin (HY-N0262) (10/100 μM; 2 h), indicating that this inductive activity requires de novo RNA synthesis[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[3]

Cell Line: Zea mays (cv. Black Mexican Sweet) suspension-cultured cells
Concentration: 10 μM
Incubation Time: 24 h
Result: Detected a 27,000 Mr polypeptide in fractions corresponding to activities b and c with maize GST I antisera.
Detected a 27,000 Mr polypeptide in fraction corresponding to activity b, and a 27,000 Mr plus a slightly reactive 26,000 Mr polypeptide in fraction corresponding to activity c with maize GST I/III antisera.
Detected a slightly reactive 26,000 Mr polypeptide in fraction corresponding to activity d with maize GST I/III antisera.
In Vivo

Subacute oral exposure of male C57BL/6J mice to Benoxacor (0.5-50 mg/kg b.w.; oral gavage; daily; for 3 consecutive days). Exposure to 50 mg/kg causes a significant dose-dependent increase in body weight-corrected liver and testicular weights, and induces mild, post-correction statistically insignificant changes in hepatic gene expression, metabolomics, and intestinal bacterial genus abundance, but exerts no effect on hepatic antioxidant enzyme activity[1].
Benoxacor (0.5-2.0 mg/L; waterborne exposure; continuous exposure; 5.5 to 72 hpf) induces concentration-dependent developmental toxicity, cardiac morphological and functional abnormalities, oxidative stress, as well as apoptosis and dysregulated expression of cardiac development-related genes in zebrafish embryos, with the most severe effects observed at the 2.0 mg/L dose[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J mice (male, 8-week-old, acclimated for 4 weeks from 4-week-old)[1]
Dosage: 0.5 mg/kg b.w.; 5 mg/kg b.w.; 50 mg/kg b.w.
Administration: p.o.; daily; 3 consecutive days
Result: Increased bodyweight-adjusted liver/testes weight significantly at 50 mg/kg.
Caused no significant changes in body weight or bodyweight-adjusted spleen, kidney, or brain weights at any dose.
Induced no overt pathological changes in liver or intestinal tissues at any dose.
Caused no significant effects on cecal microbiome α-diversity (Shannon, Chao-1 indices) or β-diversity (Weighted Unifrac distance) at any dose.
Identified 163 hepatic differentially expressed genes (DEGs) across all doses, including xenobiotic processing genes Cyp7a1, Cyp3a13, and Cyp26a1; the gene regulation profile matched that of dichloroacetic acid and sedaxane, with 15/16 and 15/21 consistent DE targets respectively, though this was not significant after multiple comparison correction.
Altered 9 serum and 15 liver metabolites before multiple comparison correction; in liver, creatinine and trigonelline were significantly altered, but no changes remained significant after false discovery rate correction.
Caused no significant changes in hepatic catalase, glutathione peroxidase (GPx), superoxide dismutase (SOD), or glutathione S-transferase (GST) activity at any dose.
Animal Model: wild-type AB; transgenic Tg Zebrafish (myl7:GFP) (embryos, exposed at 5.5 hours post-fertilization)[2]
Dosage: 0.5 mg/L; 1.0 mg/L; 2.0 mg/L
Administration: aqueous exposure; continuous; 5.5 to 72 hpf
Result: Increased total mortality rate in a concentration-dependent manner, reaching ~13% at 72 hpf for the 2.0 mg/L dose, ~10% for the 1.0 mg/L dose, and ~6% for the 0.5 mg/L dose.
Reduced heart rate significantly in a concentration-dependent manner, with the 2.0 mg/L dose causing the greatest reduction relative to controls.
Reduced hatching rate significantly in a concentration-dependent manner at both 48 and 72 hpf, with the 2.0 mg/L dose resulting in the lowest hatching rate (~40%) at 72 hpf.
Induced pericardial edema and linear stretching of the heart, with failure of heart cyclization observed in all treated groups; revealed abnormalities in the myocardial layer and linearized atria/ventricles via histological analysis.
Increased ROS fluorescence intensity significantly in a concentration-dependent manner, with the 2.0 mg/L dose showing the highest intensity (~65,000 fluorescence units).
Elevated SOD and CAT activities in a concentration-dependent manner.
Decreased MDA content at 0.5 mg/L and 1.0 mg/L, then significantly increased it at 2.0 mg/L (~3.5 nmol/mL).
Upregulated relative mRNA levels of pro-apoptotic gene caspase 3 (peak ~3.2-fold at 1.0 mg/L) and cardiac development-related genes nkx2.5, myh6, tbx5a, vmhc, and nppa.
Downregulated relative mRNA levels of gata4 and tbx2b in a concentration-dependent manner, with caspase 9 showing a slight concentration-dependent decrease.
Molecular Weight

260.12

Formula

C11H11Cl2NO2

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

ClC(Cl)C(N1C(C)COC2=CC=CC=C21)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

Solvent & Solubility
In Vitro: 

DMSO : 125 mg/mL (480.55 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.8444 mL 19.2219 mL 38.4438 mL
5 mM 0.7689 mL 3.8444 mL 7.6888 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.8444 mL 19.2219 mL 38.4438 mL 96.1095 mL
5 mM 0.7689 mL 3.8444 mL 7.6888 mL 19.2219 mL
10 mM 0.3844 mL 1.9222 mL 3.8444 mL 9.6109 mL
15 mM 0.2563 mL 1.2815 mL 2.5629 mL 6.4073 mL
20 mM 0.1922 mL 0.9611 mL 1.9222 mL 4.8055 mL
25 mM 0.1538 mL 0.7689 mL 1.5378 mL 3.8444 mL
30 mM 0.1281 mL 0.6407 mL 1.2815 mL 3.2036 mL
40 mM 0.0961 mL 0.4805 mL 0.9611 mL 2.4027 mL
50 mM 0.0769 mL 0.3844 mL 0.7689 mL 1.9222 mL
60 mM 0.0641 mL 0.3204 mL 0.6407 mL 1.6018 mL
80 mM 0.0481 mL 0.2403 mL 0.4805 mL 1.2014 mL
100 mM 0.0384 mL 0.1922 mL 0.3844 mL 0.9611 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Benoxacor
Cat. No.:
HY-W020788
Quantity:
MCE Japan Authorized Agent: